SEARCH

SEARCH BY CITATION

References

  • 1
    Spiess M. The asialoglycoprotein receptor: a model for endocytic transport receptors. Biochemistry 1990; 29:1000910018.
  • 2
    Stockert RJ. The asialoglycoprotein receptor: relationship between structure, function, and expression. Physiol Rev 1995; 75:591609.
  • 3
    Spiess M, Lodish H. Sequence of a second human asialoglycoprotein receptor: conservation of two receptor genes during evolution. Proc Natl Acad Sci U S A 1985; 82:64656469.
  • 4
    Schwartz AL. Trafficking of asialoglycoproteins and the asialoglycoprotein receptor. In: WuGY, WuCH, eds. Liver Diseases. Target Diagnosis and Therapy Using Specific Receptors and Ligands. New York: Dekker, 1991:339.
  • 5
    McFarlane BM. Hepatocellular membrane antigens. In: McFarlaneIG, WilliamsR, eds. Molecular Basis of Autoimmune Hepatitis, Austin: R.G. Landes, 1996:75104.
  • 6
    McFarlane BM, McSorley CG, Vergani D, McFarlane IG, Williams R. Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. J Hepatol 1986; 3:196205.
  • 7
    Treichel U, Poralla T, Hess G, Manns M, Meyer zum Buschenfelds K-H. Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis. Hepatology 1990; 11:606612.
  • 8
    Diao J, Michalak TI. Virus-induced anti-asialoglycoprotein receptor autoimmunity in experimental hepadnaviral hepatitis. Hepatology 1997; 25:689696.
  • 9
    Michalak TI. The woodchuck animal model of hepatitis B. Viral Hepat Rev 1998; 4:139165.
  • 10
    Diao J, Michalak TI. Composition, antigenic properties and hepatocyte surface expression of the woodchuck asialoglycoprotein receptor. J Recept Cell Signal Transduct Res 1996; 16:243271.
  • 11
    Diao J, Churchill ND, Michalak TI. Complement-mediated cytotoxicity and inhibition of ligand binding to hepatocytes by woodchuck hepatitis virus-induced autoantibodies to asialoglycoprotein receptor. Hepatology 1998; 27:16231631.
  • 12
    Michalak TI, Pardoe IU, Coffin CS, Churchill ND, Freake DS, Smith P, Trelegan CL. Occult life-long persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 1999; 29:928938.
  • 13
    Coffin CS, Michalak TI. Persistence of infectious virus in the offspring of woodchuck mothers recovered from viral hepatitis. J Clin Invest 1999; 104:203212.
  • 14
    Lew Y-Y, Michalak TI. In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus. J Virol 2001; 75:17701782.
  • 15
    Michalak TI, Lin B, Churchill ND, Dzwonkowski P, Desousa JRB. Hepadna virus nucleocapsid and surface antigens and the antigen-specific antibodies associated with hepatocyte plasma membranes in experimental woodchuck acute hepatitis. Lab Invest 1990; 62:680689.
  • 16
    Michalak TI, Lin B. Molecular species of hepadnavirus core and envelope polypeptides in hepatocyte plasma membrane of woodchucks with acute and chronic viral hepatitis. Hepatology 1994; 20:275286.
  • 17
    Hodgson PD, Michalak TI. Augmented hepatic interferon gamma expression and T-cell influx characterize acute hepatitis progressing to recovery and residual lifelong virus persistence in experimental adult woodchuck hepatitis virus infection. Hepatology 2001; 34:10491059.
  • 18
    Michalak TI, Churchill ND. Interaction of woodchuck hepatitis surface antigen with hepatocyte plasma membrane in woodchuck chronic hepatitis. Hepatology 1988; 8:499506.
  • 19
    Churchill ND, Michalak TI. WHV hepatocyte culture models. In: LauJYN, HamatakeR, eds. Hepatitis B Protocols. Totowa: Humana Press Inc. (in press).
  • 20
    Michalak TI, Hodgson PD, Churchill ND. Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection. J Virol 2000; 74:44834494.
  • 21
    Michalak TI. Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model. Immunol Rev 2000; 174:98111.
  • 22
    Cote PJ, Korba BE, Miller RH, Jacob JR, Baldwin BH, Hornbuckle WE, Purcell RH, et al. Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection. Hepatology 2000; 31:190200.
  • 23
    Michalak TI, Lau JYN, McFarlane BM, Alexander GJM, Eddleston ALWF, Williams R. Antibody-directed complement-mediated cytotoxicity to hepatocytes from patients with chronic hepatitis B. Clin Exp Immunol 1995; 100:227232.
  • 24
    Ikeda T, Kurebayashi Y. A rat model of acute liver necrosis induced by a monoclonal antibody to liver-specific antigen and complement. Hepatology 1991; 13:11521157.
  • 25
    Chiavato L, Bassi P, Santini F, Mammoli C, Lapi P, Carayon P, Pinchera A. Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 1993; 77:17001705.
  • 26
    Radillo O, Nocera A, Leprini A, Barocci S, Mollnes TE, Pocecco M, Pausa M, et al. Complement-fixing islet cell antibodies in type-1 diabetes can trigger the assembly of terminal complement complex on human islet cells and are potentially cytotoxic. Clin Immunol Immunopathol 1996; 79:217223.
  • 27
    Cui J, Arita Y, Bystryn J-C. Cytolytic antibodies to melanocytes in vitiligo. J Invest Dermatol 1993; 100:812815.